Single-shot HIV treatment suppresses virus 10,000-fold for months, animal study finds - Livescien...

Single-shot HIV treatment suppresses virus 10,000-fold for months, animal study finds  Livescience.com

The search for an HIV cure - aidsmap

The search for an HIV cure  aidsmap

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls - World Health...

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls  World Health Organization (WHO)

UVA Health Effort Aims to Improve HIV Care Across America - UVA Health Newsroom

UVA Health Effort Aims to Improve HIV Care Across America  UVA Health Newsroom

Amidst stalled HIV prevention, WHO supports new long-acting prevention drug cabotegravir - UN News

Amidst stalled HIV prevention, WHO supports new long-acting prevention drug cabotegravir  UN News

Monthly HIV injection could free patients from gruelling drug regimen - Nature.com

Monthly HIV injection could free patients from gruelling drug regimen  Nature.com

U.S. FDA approves Gilead's long-acting HIV drug Sunlenca - Reuters

U.S. FDA approves Gilead's long-acting HIV drug Sunlenca  Reuters

Classes of Antiretrovirals and How They Work - Verywell Health

Classes of Antiretrovirals and How They Work  Verywell Health

Will post-treatment controllers guide us towards an HIV cure? - aidsmap

Will post-treatment controllers guide us towards an HIV cure?  aidsmap

So far, Poland has seen fewer Ukrainian refugees with HIV than expected - aidsmap

So far, Poland has seen fewer Ukrainian refugees with HIV than expected  aidsmap

Two-thirds of people living with HIV would like to try injectable treatment, according to Europea...

Two-thirds of people living with HIV would like to try injectable treatment, according to European survey  aidsmap

HIV services in Ukraine resilient but starting to feel the strain - aidsmap

HIV services in Ukraine resilient but starting to feel the strain  aidsmap

SEARCH study finds universal 'test and treat' reduces infant HIV - aidsmap

SEARCH study finds universal 'test and treat' reduces infant HIV  aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV - aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV  aidsmap

European AIDS Treatment Group documents the impact of COVID on HIV services throughout Europe - a...

European AIDS Treatment Group documents the impact of COVID on HIV services throughout Europe  aidsmap

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds...

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds  aidsmap

Second-line treatment nearly nine times more expensive than first-line in upper-middle income cou...

Second-line treatment nearly nine times more expensive than first-line in upper-middle income countries  aidsmap

Islatravir plus doravirine remains effective at 96 weeks - aidsmap

Islatravir plus doravirine remains effective at 96 weeks  aidsmap

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing ...

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy  aidsmap

HIV infections lowered by 30% in universal testing and treatment study - aidsmap

HIV infections lowered by 30% in universal testing and treatment study  aidsmap

Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries - aid...

Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries  aidsmap

What are the roles of TAF and integrase inhibitors in weight gain? - aidsmap

What are the roles of TAF and integrase inhibitors in weight gain?  aidsmap

GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options - FierceP...

GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options  FiercePharma

Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people ...

Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people shows  aidsmap

Further evidence that recycling tenofovir in second-line treatment is effective - aidsmap

Further evidence that recycling tenofovir in second-line treatment is effective  aidsmap

South Africa: dropping out of HIV care is deadly - aidsmap

South Africa: dropping out of HIV care is deadly  aidsmap

US regulators approve new two-drug combination pill for HIV - aidsmap

US regulators approve new two-drug combination pill for HIV  aidsmap

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir - aidsmap

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir  aidsmap

Unique transgender vulnerabilities require tailored and specific interventions - aidsmap

Unique transgender vulnerabilities require tailored and specific interventions  aidsmap

Oral six-month treatment for MDR-TB is safe and effective in people with HIV - aidsmap

Oral six-month treatment for MDR-TB is safe and effective in people with HIV  aidsmap

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment - aidsmap

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment  aidsmap

Integrase inhibitors do not raise cardiovascular risk in people starting HIV treatment - aidsmap

Integrase inhibitors do not raise cardiovascular risk in people starting HIV treatment  aidsmap

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women - aid...

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women  aidsmap

Gene therapy or immunotherapy: which approach is more likely to deliver a cure for HIV? - aidsmap

Gene therapy or immunotherapy: which approach is more likely to deliver a cure for HIV?  aidsmap

Dolutegravir recommended for all in new World Health Organization guidelines - aidsmap

Dolutegravir recommended for all in new World Health Organization guidelines  aidsmap

South Africa saves $326 million on dolutegravir - aidsmap

South Africa saves $326 million on dolutegravir  aidsmap

Using marijuana for breast cancer: How it works, safety, and benefits - Medical News Today

Using marijuana for breast cancer: How it works, safety, and benefits  Medical News Today

ADVANCE trial shows dolutegravir is highly effective in South Africa - aidsmap

ADVANCE trial shows dolutegravir is highly effective in South Africa  aidsmap

Why I injected myself with an untested gene therapy - BBC

Why I injected myself with an untested gene therapy  BBC

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin) ...

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin)  aidsmap

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin) - aidsmap

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin)  aidsmap

Clinics will need new systems to administer injectable HIV therapies, says Canadian early adopter...

Clinics will need new systems to administer injectable HIV therapies, says Canadian early adopter (Mandarin)  aidsmap